RESUMEN
Mutation analysis was performed in four apparently unrelated Dutch families with pantothenate kinase-associated neurodegeneration, formerly known as Hallervorden-Spatz syndrome. A novel 3-bp deletion encompassing the nucleotides GAG at positions 1,142 to 1,144 of exon 5 of the PANK2 gene was found in all patients. One patient was compound heterozygous; she also carried a novel nonsense mutation (Ser68Stop). The other patients were homozygous for the 1142_1144delGAG mutation. The 1142_1144delGAG mutation was also found in a German patient of unknown descent. We used polymorphic microsatellite markers flanking the PANK2 gene (spanning a region of approximately 8 cM) for haplotype analyses in all these families. A conserved haplotype of 1.5 cM was found for the 1142_1144delGAG mutation carriers. All the Dutch families originated from the same geographical region within the Netherlands. The results indicate a founder effect and suggest that the 1142_1144delGAG mutation probably originated from one common ancestor. It was estimated that this mutation arose at the beginning of the ninth century, approximately 38 generations ago.
Asunto(s)
Eliminación de Gen , Enfermedades Neurodegenerativas/genética , Enfermedades Neurodegenerativas/patología , Neurodegeneración Asociada a Pantotenato Quinasa/genética , Fosfotransferasas (Aceptor de Grupo Alcohol)/genética , Secuencia de Bases , Niño , Preescolar , Femenino , Efecto Fundador , Homocigoto , Humanos , Masculino , Repeticiones de Microsatélite , Datos de Secuencia Molecular , Países Bajos , Linaje , Polimorfismo GenéticoRESUMEN
The survival motor neuron (SMN) gene has been described as a determining gene for spinal muscular atrophy (SMA). SMN has a closely flanking, nearly identical copy (cBCD541). Gene and copy gene can be discriminated by sequence differences in exons 7 and 8. The large majority of SMA patients show homozygous deletions of at least exons 7 and 8 of the SMN gene. A minority of patients show absence of SMN exon 7 but retention of exon 8. This is explained by results of our present analysis of 13 such patients providing evidence for apparent gene-conversion events between SMN and the centromeric copy gene. Instead of applying a separate analysis for absence or presence of SMN exons 7 and 8, we used a contiguous PCR from intron 6 to exon 8. In every case we found a chimeric gene with a fusion of exon 7 of the copy gene and exon 8 of SMN and absence of a normal SMN gene. Similar events, including the fusion counterpart, were observed in a group of controls, although in the presence of a normal SMN gene. Chimeric genes as the result of fusions of parts of SMN and cBCD541 apparently are far from rare and may partly explain the frequently observed SMN deletions in SMA patients.
Asunto(s)
Cromosomas Humanos Par 5 , Conversión Génica , Atrofia Muscular Espinal/genética , Proteínas del Tejido Nervioso/genética , Proteína de Unión a Elemento de Respuesta al AMP Cíclico , Electroforesis en Gel de Agar , Exones , Humanos , Intrones , Reacción en Cadena de la Polimerasa , Proteínas de Unión al ARN , Mapeo Restrictivo , Proteínas del Complejo SMNRESUMEN
With the localisation of the gene for the autosomal recessive forms of proximal spinal muscular atrophies (SMA) to the chromosomal region 5q13 and the later detection of homozygous deletions of the SMN gene located in this region, prenatal prediction of SMA has become feasible and is widely applied now. In our experience with 77 prenatal predictions of SMA, follow-up of the 39 liveborn children from these pregnancies never led to a false-negative result. Application of SMN deletion analysis has consequences for prenatal prediction of SMA. When the index patient has a homozygously deleted exon 7 of the SMN gene, prenatal prediction and interpretation of results are straightforward. In families in which no DNA from the index patient is available, prenatal detection of a homozygous SMN deletion may be considered almost proof of SMA in the fetus. Absence of a deletion, however, will not guarantee an unaffected child. A real problem exists if the index patient does not show a homozygous deletion of SMN exon 7. In such cases with non-homozygous SMN deletions, one cannot be certain of 5q linkage and autosomal recessive inheritance until other SMN mutations are detected. This is an argument to abstain from prenatal diagnosis by linkage analysis in these families.
Asunto(s)
Cromosomas Humanos Par 5/genética , Enfermedades Fetales/genética , Atrofia Muscular Espinal/genética , Proteínas del Tejido Nervioso/genética , Diagnóstico Prenatal/métodos , Proteína de Unión a Elemento de Respuesta al AMP Cíclico , Femenino , Humanos , Países Bajos , Embarazo , Proteínas de Unión al ARN , Proteínas del Complejo SMN , Eliminación de SecuenciaRESUMEN
The RET proto-oncogene, a transmembrane tyrosine kinase receptor, is involved in the development of at least five different disease phenotypes. RET is activated through somatic rearrangements in a number of cases of papillary thyroid carcinoma while germ-line point mutations are associated with three inherited cancer syndromes MEN 2A, MEN 2B and FMTC. Moreover, point mutations or heterozygous deletions of RET are found in the dominant form of Hirschsprung disease or congenital colonic aganglionosis. We cloned the entire RET genomic sequence in a contig of cosmids encompassing 150 kb, from the CA repeat sTCL-2 to the region upstream the RET promoter, and established the position of the 20 exons of the RET gene with respect to a detailed restriction map based on eight endonucleases. A new highly polymorphic CA repeat sequence was identified within intron 5 of RET (RET-INT5). Finally the orientation of RET on chromosome 10q11.2 made it possible to orientate three other genes rearranged with RET in papillary thyroid carcinomas, namely H4/D10S170 on 10q21, R1 alpha on 17q23 and RFG2/Ele1 on 10q11.2.
Asunto(s)
Cromosomas Humanos Par 10 , Proteínas de Drosophila , Reordenamiento Génico , Hominidae/genética , Proteínas Proto-Oncogénicas/genética , Proto-Oncogenes , Proteínas Tirosina Quinasas Receptoras/genética , Animales , Secuencia de Bases , Carcinoma Medular/genética , Carcinoma Papilar/genética , Mapeo Cromosómico , Cromosomas Humanos Par 17 , Cósmidos , Cartilla de ADN , Exones , Enfermedad de Hirschsprung/genética , Humanos , Intrones , Datos de Secuencia Molecular , Neoplasia Endocrina Múltiple Tipo 2a/genética , Neoplasia Endocrina Múltiple Tipo 2b/genética , Mutación Puntual , Reacción en Cadena de la Polimerasa , Regiones Promotoras Genéticas , Proto-Oncogenes Mas , Proteínas Proto-Oncogénicas c-ret , Secuencias Repetitivas de Ácidos Nucleicos , Mapeo Restrictivo , Neoplasias de la Tiroides/genéticaRESUMEN
A 760-kb YAC was constructed by homologous recombination in yeast, containing the genes located in the distal portion of the DMD gene. The YAC was introduced in mouse LA-9 cells by PEG-mediated cell fusion. One transformant accommodated an intact DMD-YAC, i.e. a full copy of the DMD internal Dp 116, Dp 71 and Dp 40 genes (apo-dystrophin-2, -1 and -3, respectively). We have studied the expression of the various gene products derived from the introduced DMD-YAC. RT-PCR revealed expression of human Dp 71 but not of Dp 116 or Dp 40. Remarkably, differences were observed in processing of the 3' region of the endogenous mouse and the human transcripts, due to different splicing of exons 71 (absent in human and present in mouse transcript) and 78 (present in human and absent in mouse transcript). The splicing pattern of the human transcript is the same as that of the major Dp 71 (apo-dystrophin-1) product in human blood. The observed splicing differences may be caused by either species-specific exon use and/or by cis-acting factors, e.g. the upstream transcript composition, because we have no evidence for endogenous Dp 71 expression.
Asunto(s)
Distrofina/análogos & derivados , Técnicas de Transferencia de Gen , Animales , Secuencia de Bases , Cromosomas Artificiales de Levadura , Cartilla de ADN/genética , ADN Complementario/genética , Distrofina/genética , Exones , Regulación de la Expresión Génica , Humanos , Células Híbridas , Hibridación Fluorescente in Situ , Células L , Ratones , Datos de Secuencia Molecular , Distrofias Musculares/genética , Reacción en Cadena de la Polimerasa , Regiones Promotoras Genéticas , ARN/genética , Empalme del ARNRESUMEN
YACs from the region containing the spinal muscular atrophy (SMA) locus at 5q12 have been used as probes in a direct screening of cDNA libraries to isolate 8 cDNAs, mapped to different YAC fragments. Three clones showed complete identity to the genes for cyclin B1 (CCNB1), the p44 subunit of the transcription factor BTF2 (BTF2p44), and cofilin (CFL). Two clones showed partial identity to the beta-glucuronidase gene (GLCB) and a rat integral membrane glycoprotein gene (RNINMEGLA). CFL turned out to have been identified by a pseudogene sequence. Related sequences occurred on other chromosomes. CCNB1 and BTF2p44 were given an exact location. The GLCB-like gene and the RNINMEGLA-like gene detected loci on both 5q and 5p. The remaining three cDNA clones were localized to the SMA region only. Their sequences did not show identity to any gene for which a function is already known. Two of them have now turned out to be identical to recently reported candidate genes for SMA.
Asunto(s)
Cromosomas Humanos Par 5 , Proteínas de Microfilamentos , Atrofia Muscular Espinal/genética , Proteínas del Tejido Nervioso/genética , Factores de Transcripción TFII , Factores Despolimerizantes de la Actina , Northern Blotting , Mapeo Cromosómico , Cromosomas Artificiales de Levadura , Proteína de Unión a Elemento de Respuesta al AMP Cíclico , Ciclinas/genética , ADN Helicasas/genética , ADN Complementario , Humanos , Proteína Inhibidora de la Apoptosis Neuronal , Especificidad de Órganos , ARN Mensajero/análisis , Proteínas de Unión al ARN , Mapeo Restrictivo , Proteínas del Complejo SMN , Factor de Transcripción TFIIH , Factores de Transcripción/genética , Transcripción GenéticaRESUMEN
The human dystrophin gene, mutations of which cause Duchenne and Becker muscular dystrophy, measures 2.4 Mb. This size seriously limits its cloning as a single DNA fragment and subsequent in-vitro expression studies. We have used stepwise in-vivo recombination between overlapping yeast artificial chromosomes (YACs) to reconstruct the dystrophin gene. The recombinant YACs are mitotically stable upon propagation in haploid yeast cells. In contrast, specific combinations of YACs display a remarkable mitotic and meiotic instability in diploid cells. Non-disjunction is rare for overlapping YACs, but increases upon sporulation of diploid cells containing non-overlapping molecules. We have exploited this feature in a three-point recombination to bridge a 280 kb gap between two non-overlapping YACs for which no YAC of proper polarity existed. Our largest recombinant YAC measures 2.3 Mb and contains the entire muscle specific DMD-gene with the exception of a 100 kb region containing the in-frame exon 60. The latter segment has a high tendency to undergo deletions in multi-molecular interactions, probably due to the presence of as yet unidentified instability-enhancing sequences. Fluorescent in situ hybridizations confirmed that the 2.3 Mb DMD YAC contained Xp21-sequences only and indicated a compact tertiary structure of the DMD-gene in interphase lymphocyte nuclei. We conclude that the yeast system is a flexible, efficient and generally applicable tool to reconstruct or build genomic regions from overlapping YAC constituents. Its application to the human dystrophin gene has provided many possibilities for future studies.
Asunto(s)
Distrofina/genética , Distrofias Musculares/genética , Mutación , Cromosoma X , Cromosomas Fúngicos , Clonación Molecular/métodos , Cruzamientos Genéticos , Humanos , Hibridación in Situ , Recombinación Genética , Saccharomyces cerevisiae/genéticaRESUMEN
Previously we identified a novel 6.5 kb mRNA transcribed from the Duchenne muscular dystrophy (DMD) gene. This mRNA differs in coding content and tissue distribution from the known muscle type and brain type 14 kb DMD mRNAs which code for dystrophin. The novel transcript shares with dystrophin most of the sequence coding for the cysteine-rich and C-terminal domains. Here we used cDNA cloning to identify the divergence point between the common region and the sequence unique to the novel mRNA at the 5' end of the sequence encoding the cysteine-rich domain of dystrophin. This unique sequence containing the translation initiation site is located in a new exon in the intron between exons 62 and 63 of the dystrophin gene. Using probes containing RNA sequences specific to the novel mRNA, we investigated the expression of this mRNA in various tissues and cell types. The study reveals that this mRNA is the main DMD gene product detectable in a variety of nonmuscle tissues including brain cells. The amount of this mRNA in some tissues is comparable to the amount of dystrophin mRNA in the muscle. The expression of the 6.5 kb mRNA is down-regulated during differentiation of myogenic cells; it is present in small amounts in proliferating myoblasts but is undetected in differentiated muscle cultures depleted of mononucleated cells.
Asunto(s)
Distrofina/genética , Distrofias Musculares/genética , Distrofia Muscular Animal/genética , ARN Mensajero/genética , Transcripción Genética , Animales , Secuencia de Bases , Southern Blotting , Células Cultivadas , Clonación Molecular , ADN/genética , ADN/aislamiento & purificación , Humanos , Ratones , Datos de Secuencia Molecular , Músculos/fisiología , Músculos/fisiopatología , ARN/genética , ARN/aislamiento & purificación , ARN Mensajero/análisis , ARN Mensajero/metabolismo , Ratas , Mapeo Restrictivo , Homología de Secuencia de Ácido NucleicoRESUMEN
Using whole cosmids as probes, we have mapped 242 DMD/BMD deletion breakpoints located in the major deletion hot spot of the DMD gene. Of these, 113 breakpoints were mapped more precisely to individual restriction enzyme fragments in the distal 80 kb of the 170-kb intron 44. An additional 12 breakpoints are distributed over the entire region, with no significant local variation in frequency. Furthermore, deletion sizes vary and are not influenced by the positions of the breakpoints. This argues against a predominant role of one or a few specific sequences in causing frequent rearrangements. It suggests that structural characteristics or a more widespread recombinogenic sequence makes this region so susceptible to deletion. Our study revealed several RFLPs, one of which is a 300-bp insertion/deletion polymorphism. Abnormally migrating junction fragments are found in 81% of the precisely mapped deletions and are highly valuable in the diagnosis of carrier females.
Asunto(s)
Distrofina/genética , Cromosoma X/ultraestructura , Deleción Cromosómica , Mapeo Cromosómico , Cósmidos , Femenino , Frecuencia de los Genes , Genes , Humanos , Masculino , Distrofias Musculares/genética , Polimorfismo de Longitud del Fragmento de Restricción , Recombinación GenéticaRESUMEN
We have studied 34 Becker and 160 Duchenne muscular dystrophy (DMD) patients with the dystrophin cDNA, using conventional blots and FIGE analysis. One hundred twenty-eight mutations (65%) were found, 115 deletions and 13 duplications, of which 106 deletions and 11 duplications could be precisely mapped in relation to both the mRNA and the major and minor mutation hot spots. Junction fragments, ideal markers for carrier detection, were found in 23 (17%) of the 128 cases. We identified eight new cDNA RFLPs within the DMD gene. With the use of cDNA probes we have completed the long-range map of the DMD gene, by the identification of a 680-kb SfiI fragment containing the gene's 3' end. The size of the DMD gene is now determined to be about 2.3 million basepairs. The combination of cDNA hybridizations with long-range analysis of deletion and duplication patients yields a global picture of the exon spacing within the dystrophin gene. The gene shows a large variability of intron size, ranging from only a few kilobases to 160-180 kb for the P20 intron.
Asunto(s)
Deleción Cromosómica , ADN/genética , Familia de Multigenes , Proteínas Musculares/genética , Distrofias Musculares/genética , Sondas de ADN , Distrofina , Exones , Tamización de Portadores Genéticos , Humanos , Intrones , Mutación , Polimorfismo de Longitud del Fragmento de Restricción , Mapeo RestrictivoRESUMEN
We report a family with an X-linked recessive disorder characterized by muscle cramps and myalgia. Nine affected male family members had high resting serum levels of creatine kinase, and well-developed musculature with calf hypertrophy but no evidence of muscular weakness. Symptoms began in childhood and did not progress. Electromyographic findings were consistent with myopathy while muscle biopsies showed nonspecific myopathic changes without evidence of storage of glycogen or lipid. Analysis of DNA revealed a deletion in the 1st third of the dystrophin gene. Western blot analysis revealed that dystrophin was smaller than that in normal samples, with no reduction in the amount of the protein present. This disorder represents a new clinical phenotype associated with a deletion in the dystrophin gene. This deletion affects a portion of the dystrophin molecule that clinically does not appear to significantly alter its function. Other patients with deletions in this region may have truncated dystrophin without clinical signs of progressive muscle disease.
Asunto(s)
Deleción Cromosómica , Ligamiento Genético , Calambre Muscular/etiología , Proteínas Musculares/genética , Enfermedades Musculares/genética , Dolor , Cromosoma X , Adulto , Preescolar , ADN/sangre , Distrofina , Femenino , Humanos , Masculino , Mitocondrias Musculares/enzimología , Proteínas Musculares/análisis , Músculos/análisis , Enfermedades Musculares/complicaciones , Enfermedades Musculares/fisiopatología , LinajeRESUMEN
In 288 Dutch and Belgian Duchenne and Becker muscular dystrophy families, the parental origin of 41 new deletion or duplication mutations was determined. Twenty seven of the new mutations occurred in the maternal X chromosome and nine in the grandmaternal and five in the grandpaternal X chromosome. The grandparental data are compatible with equal mutation rates for DMD in male and female X chromosomes. New mutations were defined by their presence in one or more progeny and absence in the lymphocytes of the mother or the grandparents. In one family a fraction of the maternal lymphocytes was found to carry the mutation, suggesting somatic mosaicism. In six cases out of 41, the mutation was transmitted more than once by a parent in whom the mutation was absent in lymphocytes, suggesting gonadal mosaicism as the explanation for the multiple transmission. Using our data for the recurrence of the mutations among the total of at risk haplotypes transmitted, we arrive at a recurrence risk of 14% for the at risk haplotype. The observation of this high risk of germinal mosaicism is crucially important for all physicians counselling females in DMD families. Recently, germinal mosaicism has been observed also in a number of other X linked and autosomal disorders. The implications and appropriate diagnostic precautions are discussed.
Asunto(s)
Mosaicismo , Distrofias Musculares/genética , Sondas de ADN , Femenino , Asesoramiento Genético , Pruebas Genéticas , Haplotipos , Humanos , Masculino , Mutación , Linaje , Recurrencia , Factores de RiesgoRESUMEN
The locus DXS269 (P20) defines a deletion hotspot in the distal part of the Duchenne Muscular Dystrophy gene. We have cloned over 90 kilobase-pairs of genomic DNA from this region in overlapping cosmids. The use of whole cosmids as probes in a competitive DNA hybridization analysis proves a fast and convenient method for identifying rearrangements in this region. A rapid survey of P20-deletion patients is carried out to elucidate the nature of the propensity to deletions in this region. Using this technique, deletion breakpoints are pinpointed to individual restriction fragments in patient DNAs without the need for tedious isolation of single copy sequences. Simultaneously, the deletion data yield a consistent restriction map of the region and permit detection of several RFLPs. A 176 bp exon was identified within the cloned DNA, located 3' of an intron exceeding 150 Kb in length. Its deletion causes a frameshift in the dystrophin reading frame and produces the DMD phenotype. This exon is one of the most frequently deleted exons in BMD/DMD patients and its sequence is applied in a pilot study for diagnostic deletion screening using Polymerase Chain Reaction amplification.
Asunto(s)
Deleción Cromosómica , Cósmidos , Genes , Distrofias Musculares/genética , Secuencia de Bases , Línea Celular , ADN/genética , ADN/aislamiento & purificación , Distrofina , Exones , Humanos , Datos de Secuencia Molecular , Proteínas Musculares/genética , Mutación , Hibridación de Ácido Nucleico , Sondas de Oligonucleótidos , Polimorfismo de Longitud del Fragmento de Restricción , Mapeo RestrictivoAsunto(s)
ADN/análisis , Tamización de Portadores Genéticos , Pruebas Genéticas , Distrofias Musculares/genética , Femenino , Predicción , Tamización de Portadores Genéticos/métodos , Asesoramiento Genético , Gónadas/ultraestructura , Humanos , Masculino , Mosaicismo , Distrofias Musculares/diagnóstico , Linaje , Embarazo , Diagnóstico PrenatalRESUMEN
Application of molecular genetic techniques has greatly increased diagnostic possibilities of hereditary disorders. In 1983 the first linkage of Duchenne muscular dystrophy with flanking DNA probes was described, which made carrier detection possible in a limited number of cases. The first published prenatal diagnosis for Duchenne muscular dystrophy dates from 1985. DNA-analysis for Duchenne muscular dystrophy and Becker muscular dystrophy has become increasingly informative, firstly by the development of more flanking markers, followed by intragenic probes detecting deletions and, more recently, by the use of cDNA probes detecting a deletion or duplication mutation in over 60% of the Duchenne and Becker muscular dystrophy patients. Although these developments allow a highly reliable (greater than 99%) carrier detection and prenatal diagnosis in over 90% of cases, the continuing introduction of new probes and/or technologies has necessitated constant reappraisal of many families to derive maximum information. During the past 3 years we applied prenatal diagnosis for Duchenne and Becker muscular dystrophies with DNA-analysis on 53 male fetuses in 47 families. Twenty-two healthy male babies were born, after being diagnosed to have a low Duchenne muscular dystrophy risk. Two pregnancies also diagnosed as low risk have not yet come to term. In the other cases a high risk for Duchenne muscular dystrophy was found and the parents chose abortion. Our studies also revealed a number of important diagnostic pitfalls, such as non-paternity, karyotypic anomalies and gonadal mosaicism.
Asunto(s)
Distrofias Musculares/diagnóstico , Diagnóstico Prenatal , ADN/análisis , Femenino , Humanos , Cariotipificación , Linaje , EmbarazoRESUMEN
We have made a detailed study of a deletion hot spot in the distal half of the Duchenne muscular dystrophy (DMD) gene, using intragenic probe P20 (DXS269), isolated by a hybrid cell-mediated cloning procedure. P20 detects 16% deletions in patients suffering from either DMD or Becker muscular dystrophy (BMD), in sharp contrast to the adjacent intragenic markers JBir (7%) and J66 (less than 1%), mapping respectively 200-320 kb proximal and 380-500 kb distal to P20. Of the P20 deletions, 30% start within a region of 25-40 kb, the majority extending distally. P20 was confirmed to map internal to a distal intron of the DMD gene. This region was recently shown by both cDNA analysis (M. Koenig et al., 1987; Cell 50: 509-517), and field inversion electrophoresis studies (J.T. Den Dunnen et al., 1987, Nature (London) 329: 640-642) to be specifically prone to deletions. In addition, P20 detects MspI and EcoRV RFLPs, informative in 48% of the carrier females. Together, these properties make P20 useful for carrier detection, prenatal diagnosis, and the study of deletion induction in both DMD and BMD.